Anixa Debt Ratio from 2010 to 2024

ANIX Stock

USD 3.30 0.01 0.30%

Anixa Biosciences Debt Ratio yearly trend continues to be fairly stable with very little volatility. Debt Ratio will likely drop to 0 in 2024. During the period from 2010 to 2024, Anixa Biosciences Debt Ratio regression line of annual values had r-squared of 0.45 and arithmetic mean of 0.17. View All Fundamentals

Debt Ratio

First Reported

2010-12-31

Previous Quarter

0.001739

Current Value

0.001652

Quarterly Volatility

0.36022097

Credit Downgrade

Yuan Drop

Covid

Check Anixa Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anixa Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 216.9 K, Selling General Administrative of 4.2 M or Total Revenue of 229.4 K, as well as many indicators such as Price To Sales Ratio of 861, Dividend Yield of 0.0 or PTB Ratio of 4.39. Anixa financial statements analysis is a perfect complement when working with Anixa Biosciences Valuation or Volatility modules.

Check out the analysis of Anixa Biosciences Correlation against competitors.

For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Latest Anixa Biosciences' Debt Ratio Growth Pattern

Below is the plot of the Debt Ratio of Anixa Biosciences over the last few years. It is Anixa Biosciences' Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anixa Biosciences' overall financial position and show how it may be relating to other accounts over time.

Debt Ratio

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Debt Ratio

Timeline

Anixa Debt Ratio Regression Statistics

	Arithmetic Mean	0.17
	Geometric Mean	0.01
	Coefficient Of Variation	205.90
	Mean Deviation	0.27
	Median	0.01
	Standard Deviation	0.36
	Sample Variance	0.13
	Range	1.019
	R-Value	(0.67)
	Mean Square Error	0.08
	R-Squared	0.45
	Significance	0.01
	Slope	(0.05)
	Total Sum of Squares	1.82

Anixa Debt Ratio History

	2024	0.001652
	2023	0.001739
	2021	0.001513
	2020	0.001087
	2013	0.005839
	2012	1.02
	2011	0.89

Other Fundumenentals of Anixa Biosciences

Cash Flow To Debt Ratio

Anixa Biosciences Debt Ratio component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Net Receivables	Accounts Payable	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Long Term Investments	Intangible Assets	Long Term Debt Total	Short Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	-0.55	-0.67	-0.29	0.99	-0.34	-0.61	0.81	-0.32	0.64	0.01	0.98	0.83	-0.48	-0.16	0.26	-0.49	0.95	0.95	0.92
Total Stockholder Equity	0.98		-0.59	-0.65	-0.46	1.0	-0.27	-0.63	0.8	-0.44	0.7	0.08	0.99	0.86	-0.43	-0.25	0.26	-0.55	0.93	0.94	0.92
Net Debt	-0.55	-0.59		0.29	0.41	-0.56	0.19	0.37	0.01	0.27	-0.34	0.14	-0.49	-0.46	0.03	0.26	-0.16	0.32	-0.62	-0.63	-0.37
Retained Earnings	-0.67	-0.65	0.29		0.12	-0.67	0.85	0.02	-0.59	0.34	-0.15	0.6	-0.67	-0.77	0.85	-0.08	-0.69	0.74	-0.58	-0.59	-0.67
Total Liab	-0.29	-0.46	0.41	0.12		-0.38	-0.25	0.35	-0.22	0.76	-0.59	-0.34	-0.42	-0.43	-0.09	0.51	-0.06	0.49	-0.25	-0.27	-0.32
Total Current Assets	0.99	1.0	-0.56	-0.67	-0.38		-0.3	-0.62	0.82	-0.39	0.68	0.05	0.99	0.85	-0.46	-0.2	0.27	-0.52	0.94	0.95	0.93
Net Receivables	-0.34	-0.27	0.19	0.85	-0.25	-0.3		-0.28	-0.2	0.04	0.26	0.84	-0.28	-0.41	0.81	-0.25	-0.6	0.49	-0.25	-0.27	-0.29
Accounts Payable	-0.61	-0.63	0.37	0.02	0.35	-0.62	-0.28		-0.52	0.26	-0.63	-0.55	-0.64	-0.44	-0.22	0.53	0.38	-0.06	-0.65	-0.65	-0.65
Short Term Investments	0.81	0.8	0.01	-0.59	-0.22	0.82	-0.2	-0.52		-0.29	0.59	0.19	0.86	0.71	-0.51	-0.11	0.18	-0.41	0.7	0.7	0.87
Common Stock	-0.32	-0.44	0.27	0.34	0.76	-0.39	0.04	0.26	-0.29		-0.55	-0.09	-0.43	-0.48	0.21	0.28	-0.29	0.62	-0.26	-0.28	-0.35
Property Plant Equipment	0.64	0.7	-0.34	-0.15	-0.59	0.68	0.26	-0.63	0.59	-0.55		0.54	0.71	0.57	0.04	-0.46	-0.08	-0.25	0.64	0.64	0.66
Current Deferred Revenue	0.01	0.08	0.14	0.6	-0.34	0.05	0.84	-0.55	0.19	-0.09	0.54		0.1	-0.05	0.55	-0.39	-0.54	0.36	0.06	0.05	0.13
Net Tangible Assets	0.98	0.99	-0.49	-0.67	-0.42	0.99	-0.28	-0.64	0.86	-0.43	0.71	0.1		0.86	-0.46	-0.27	0.23	-0.52	0.91	0.92	0.94
Capital Surpluse	0.83	0.86	-0.46	-0.77	-0.43	0.85	-0.41	-0.44	0.71	-0.48	0.57	-0.05	0.86		-0.53	-0.27	0.52	-0.61	0.85	0.86	0.93
Long Term Investments	-0.48	-0.43	0.03	0.85	-0.09	-0.46	0.81	-0.22	-0.51	0.21	0.04	0.55	-0.46	-0.53		-0.47	-0.78	0.72	-0.33	-0.34	-0.46
Intangible Assets	-0.16	-0.25	0.26	-0.08	0.51	-0.2	-0.25	0.53	-0.11	0.28	-0.46	-0.39	-0.27	-0.27	-0.47		0.53	-0.2	-0.24	-0.26	-0.29
Long Term Debt Total	0.26	0.26	-0.16	-0.69	-0.06	0.27	-0.6	0.38	0.18	-0.29	-0.08	-0.54	0.23	0.52	-0.78	0.53		-0.72	0.24	0.25	0.29
Short Term Debt	-0.49	-0.55	0.32	0.74	0.49	-0.52	0.49	-0.06	-0.41	0.62	-0.25	0.36	-0.52	-0.61	0.72	-0.2	-0.72		-0.36	-0.37	-0.44
Net Invested Capital	0.95	0.93	-0.62	-0.58	-0.25	0.94	-0.25	-0.65	0.7	-0.26	0.64	0.06	0.91	0.85	-0.33	-0.24	0.24	-0.36		1.0	0.91
Net Working Capital	0.95	0.94	-0.63	-0.59	-0.27	0.95	-0.27	-0.65	0.7	-0.28	0.64	0.05	0.92	0.86	-0.34	-0.26	0.25	-0.37	1.0		0.92
Capital Stock	0.92	0.92	-0.37	-0.67	-0.32	0.93	-0.29	-0.65	0.87	-0.35	0.66	0.13	0.94	0.93	-0.46	-0.29	0.29	-0.44	0.91	0.92

Click cells to compare fundamentals

About Anixa Biosciences Financial Statements

Anixa Biosciences investors use historical fundamental indicators, such as Anixa Biosciences' Debt Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Anixa Biosciences. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Cash Flow To Debt Ratio	(162.30)	(154.18)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Anixa Debt Ratio from 2010 to 2024

Latest Anixa Biosciences' Debt Ratio Growth Pattern

Anixa Debt Ratio Regression Statistics

Anixa Debt Ratio History

Other Fundumenentals of Anixa Biosciences

Anixa Biosciences Debt Ratio component correlations

About Anixa Biosciences Financial Statements

Also Currently Popular

Additional Tools for Anixa Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY